Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Mphasis - Deal win momentum continued to be impressive - ICICI Securities

Posted On: 2020-10-25 23:46:47


We anticipated an improvement in the business prospects of some sub-verticals like capital markets to augur well for Mphasis (refer our recent note). Our thesis played out during Sep'20 with BCM revenues reporting robust growth of 17% QoQ (USD). Growth mix during Q2FY21 (Direct: +10.9%, DXC: -15.5%; QoQ, CC) yet again brings to the fore the point that concerns around DXC are overblown. Potential visibility beyond Sep'21E on back of expected strong business and operational realignment generates a positive surprise. Deal win momentum continued to be impressive (US$360mn/259mn TCV in Sep'20/Jun'20). Mphasis reported a robust increase (~75% YoY) in the deal pipeline. Ramp-up of these large deals provides strong growth visibility over the medium term (FY20-FY23E CAGR = 10.1%, USD). In conjunction with a healthy payout ratio (~55%), the stock is attractively priced (17x FY22E EPS). We maintain BUY on Mphasis with a revised price target of Rs1,885 (earlier Rs1,820).

- Sharp decline in DXC more than offset by robust growth in Direct revenues: Gross revenues grew 6% QoQ (CC), ahead of our expectation of 3.5%. The better than expected performance was driven by a robust increase in direct revenues (+10.9% QoQ, CC). Across verticals, Banking & Capital Markets (+17% QoQ, USD) was the key growth driver. Other key verticals reported either sharp declines (e.g. ITCE, Logistics & Transportation) or tepid growth (e.g. Insurance). Sharp revenue decline in DXC channel (-15.5% QoQ, CC) was a key overhang on reported performance.

Contrary to the general trend during the quarter, utilisations of Mphasis dipped (from 82% to 80%), in line with the strategy of investing in talent. Accordingly, even as gross margins expanded 150bps QoQ, the benefit was largely offset by rise in G&A expenses.

- Deal win momentum and pipeline continued to be robust: Company announced Direct TCV wins worth US$360mn, including one large deal with TCV > US$200mn. 73% of these deal wins came from new-gen areas with increased deal sizes. In addition, Mphasis hinted at 75% YoY increase in the deal pipeline. Strong business and operational realignment in DXC relationship was indicated with potential visibility beyond Sep'21E. On margins, Mphasis reiterated its intent to invest back in the business. Accordingly, we don't see material headroom for margin expansion.

- Strong growth at reasonable valuations: As highlighted in our recent note (link), even as the risk of further reduction in DXC revenues exists, we expect incremental revenues from Blackstone portfolio / strong deal win momentum in Direct to be an effective hedge. Ramp-up of recently-won large deals provides strong growth visibility over the medium term (FY20-FY23E CAGR of 10.1%, USD). In conjunction with a healthy DPR (~55%), the stock is attractively priced at 17x FY22E EPS.

Shares of MPHASIS LTD. was last trading in BSE at Rs.1381.7 as compared to the previous close of Rs. 1352.65. The total number of shares traded during the day was 25910 in over 3359 trades.

The stock hit an intraday high of Rs. 1412 and intraday low of 1374.15. The net turnover during the day was Rs. 35991228.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Views of HDFC Securities and Acuité Ratings & Research on Q2FY21 GDP Numbers

Rollover Report for November 2020 - December 2020: Angel Broking

Initiating Coverage on Godrej Properties - The housing factory - HDFC Securities

Burger King IPO - Angel Broking

Rollover Analysis - Record foreign inflows pushes Nifty to 13k - YES Securities

Ceramic tiles industry - Market share gains sustain for top branded players - ICICI Securities

Gas sector - CGD: Competition to hit margins, volumes and lead to derating - ICICI Securities

Cement - Prices resilient in Q3; consensus upgrades to continue - ICICI Securities

Specialty chemicals - Price trend in Sep-20 - ICICI Securities

Timken India - Q2FY21 Company Update - ICICI Direct

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019